Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics

Yazar: Arlett, Peter, Straus, Sabine, Rasi, Guido
Yayımlandı Clin Pharmacol Ther (2019)

The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines

Yazar: Cavaleri, Marco, Enzmann, Harald, Straus, Sabine, Cooke, Emer
Yayımlandı Lancet (2021)

Improving the Safety of Medicines in the European Union: From Signals to Action

Yazar: Potts, Joanne, Genov, Georgy, Segec, Andrej, Raine, June, Straus, Sabine, Arlett, Peter
Yayımlandı Clin Pharmacol Ther (2019)

Navigating stormy waters: 10 years of operation of the European Union Regulatory Network Incident Management Plan for Medicines for Human Use

Yazar: Santoro, Aniello, Caplanusi, Irina, Sweeney, Fergus, Cappelli, Benedicte, Nolan, Lorraine, Straus, Sabine, Arlett, Peter
Yayımlandı Pharmacoepidemiol Drug Saf (2020)

Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Sta...

Yazar: Bahri, Priya, Morales, Daniel R., Inoubli, Adrien, Dogné, Jean-Michel, Straus, Sabine M. J. M.
Yayımlandı Drug Saf (2020)

Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs

Yazar: Mazzaglia, Giampiero, Straus, Sabine M. J., Arlett, Peter, da Silva, Daniela, Janssen, Heidi, Raine, June, Alteri, Enrica
Yayımlandı Drug Saf (2017)

Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase

Yazar: Willemen, Marjolein J., Mantel-Teeuwisse, Aukje K., Straus, Sabine M., Meyboom, Ron H., Egberts, Toine C., Leufkens, Hubert G.
Baskı/Yayın Bilgisi 2011

Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European Union

Yazar: Hoeve, Christina E., Francisca, Reynold D. C., Zomerdijk, Inge, Sturkenboom, Miriam C. J. M., Straus, Sabine M. J. M.
Yayımlandı Drug Saf (2019)

Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors

Yazar: Hoeve, Christina E., de Vries, Esther, Mol, Peter G. M., Sturkenboom, Miriam C. J. M., Straus, Sabine M. J. M.
Yayımlandı Drug Saf (2020)

Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis

Yazar: Duijnhoven, Ruben G., Straus, Sabine M. J. M., Raine, June M., de Boer, Anthonius, Hoes, Arno W., De Bruin, Marie L.
Baskı/Yayın Bilgisi 2013

Baseline incidence of intussusception in early childhood before rotavirus vaccine introduction, the Netherlands, January 2008 to December 2012

Yazar: Gadroen, Kartini, Kemmeren, Jeanet M, Bruijning-Verhagen, Patricia CJ, Straus, Sabine MJM, Weibel, Daniel, de Melker, Hester E, Sturkenboom, Miriam CJM
Yayımlandı Euro Surveill (2017)

Additional safety risk to exceptionally approved drugs in Europe?

Yazar: Arnardottir, Arna H, Haaijer-Ruskamp, Flora M, Straus, Sabine M J, Eichler, Hans-Georg, de Graeff, Pieter A, Mol, Peter G M
Baskı/Yayın Bilgisi 2011

Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in Europe

Yazar: Francisca, Reynold D. C., Baba, Emna, Hoeve, Christina E., Zomerdijk, Inge M., Sturkenboom, Miriam C. J. M., Straus, Sabine M. J. M.
Yayımlandı Drug Saf (2020)

Population-based studies of antithyroid drugs and sudden cardiac death

Yazar: van Noord, Charlotte, Sturkenboom, Miriam C J M, Straus, Sabine M J M, Hofman, Albert, Witteman, Jacqueline C M, Stricker, Bruno H Ch
Baskı/Yayın Bilgisi 2009

Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment

Yazar: Teichert, Martina, Visser, Loes E, Uitterlinden, Andrė G, Hofman, Albert, Buhre, Peter J, Straus, Sabine, De Smet, Peter A G M, Stricker, Bruno HCh
Baskı/Yayın Bilgisi 2011

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project

Yazar: de Bie, Sandra, Ferrajolo, Carmen, Straus, Sabine M. J. M., Verhamme, Katia M. C., Bonhoeffer, Jan, Wong, Ian C. K., Sturkenboom, Miriam C. J. M.
Yayımlandı PLoS One (2015)

Isotretinoin exposure during pregnancy: a population-based study in The Netherlands

Yazar: Zomerdijk, Ingeborg M, Ruiter, Rikje, Houweling, Leanne M A, Herings, Ron M C, Sturkenboom, Miriam C J M, Straus, Sabine M J M, Stricker, Bruno H
Yayımlandı BMJ Open (2014)

EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantatio...

Yazar: Karres, Dominik, Ali, Sahra, van Hennik, Paula B., Straus, Sabine, Josephson, Filip, Thole, Geanne, Glerum, Pieter J., Herberts, Carla, Babae, Negar, Herold, Ralf, Papadouli, Irene, Pignatti, Francesco
Yayımlandı Oncologist (2020)

Understanding drug preferences, different perspectives

Yazar: Mol, Peter G M, Arnardottir, Arna H, Straus, Sabine M J, de Graeff, Pieter A, Haaijer-Ruskamp, Flora M, Quik, Elise H, Krabbe, Paul F M, Denig, Petra
Yayımlandı Br J Clin Pharmacol (2015)

Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action

Yazar: Radecka, Anna, Loughlin, Louise, Foy, Mick, de Ferraz Guimaraes, Margarida Viana, Sarinic, Viola Macolic, Di Giusti, Marina Dimov, Lesicar, Marina, Straus, Sabine, Montero, Dolores, Pallos, Julia, Ivanovic, Jelena, Raine, June
Yayımlandı Drug Saf (2018)